The downstream financial effect of hepatology

Hepatology

Volumn 41, Issue 5, 2005, Pages 968-975

  Cohen, Stanley Martin ^a   Gundlapalli, Sushama ^a   Shah, Ami R ^a   Johnson, Tricia J ^a   Rechner, John A ^a   Jensen, Donald M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER; CONSULTATION; CONTROLLED STUDY; DATA BASE; EVALUATION; FOLLOW UP; HEALTH CARE FINANCING; HOSPITAL ADMISSION; HOSPITAL BILLING; HOSPITAL CHARGE; HOSPITAL FINANCE; HOSPITAL PATIENT; HOSPITAL PLANNING; HUMAN; LIVER; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MONEY; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL PATIENT;

ACADEMIC MEDICAL CENTERS; ADULT; COHORT STUDIES; DATABASES, FACTUAL; GASTROENTEROLOGY; HEALTH EXPENDITURES; HOSPITAL COSTS; HOSPITAL DEPARTMENTS; HUMANS; LIVER TRANSPLANTATION; RETROSPECTIVE STUDIES;

EID: 17844363684     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20690     Document Type: Article

References (14)

1. Schneeweiss R, Ellsbury K, Hart G, Geyman JP. The economic impact and multiplier effect of a family practice clinic on an academic medical center. JAMA 1989;262:370-375.
2. Saultz JW, McCarty G, Cox B, Labby D, Williams R, Fields SA. Indirect institutional revenue generated from an academic primary care clinical network. Fam Med 2001;33:668-671.
3. American Board of Internal Medicine. Transplant hepatology exam certification. Available at: http://www.abim.org/cert/aqthep.shtm.
4. United Network for Organ Sharing. UNOS bylaws, appendix B, attachment I. Available at: http://www.unos.Org/policiesandBylaws/byLaws/docs/bylaw_ 116.doc.
5. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998;47:1-39.
6. Wong JB, McQuillan GM, McHutchison J, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-1569.
7. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. HEPATOLOGY 2000;31:777-782.
8. Kim WR, Brown RS, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. HEPATOLOGY 2002;36:227-242.
9. Kim WR. The burden of hepatitis C in the United States. HEPATOLOGY 2002;36:S30-S34.
10. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:331-338.
11. Hoofnagle JH. Liver disease research funding. HEPATOLOGY 2004;39:279.
12. Provenzale D. Economic considerations for the hepatologist. HEPATOLOGY 1999;29:S13-S17.
13. Provenzale D. An overview of economic analysis for the practicing gastroenterologist and hepatologist. Eur J Gastroenterol Hepatol 2004;16:513-517.
14. Fennerty MB. Academic medicine under managed care. Gastroenterol Clin North Am 1997;26:911-921.